Work

Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience

Year: 2019

Type: article

Study design: Observational Study

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.1080/10428194.2019.1573996

Authors: Filiz Yucebay, Christina Matthews, Marcin Puto, Junan Li, Basem William, Samantha M. Jaglowski, Sam L. Penza, Sumithira Vasu, Don M. Benson, Leslie A. Andritsos, Steven M. Devine, Yvonne A. Efebera, Julianna V. F. Roddy

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Roswell Park Comprehensive Cancer Center, The Ohio State University

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2913648495

FWCI: 2.374

Cites: 12

Cited by: 21

Related to: 10